Cas:203792-49-8 methyl 5-carbonochloridoyl-1-methylpyrazole-3-carboxylate manufacturer & supplier

We serve Chemical Name:methyl 5-carbonochloridoyl-1-methylpyrazole-3-carboxylate CAS:203792-49-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

methyl 5-carbonochloridoyl-1-methylpyrazole-3-carboxylate

Chemical Name:methyl 5-carbonochloridoyl-1-methylpyrazole-3-carboxylate
CAS.NO:203792-49-8
Synonyms:1H-PYRAZOLE-3-CARBOXYLIC ACID,5-(CHLOROCARBONYL)-1-METHYL-,METHYL ESTER;methyl5-(chlorocarbonyl)-1-methyl-1H-pyrazole-3-carboxylate;1-methyl-3-methoxycarbonylpyrazole-3-carboxylic acid chloride
Molecular Formula:C7H7ClN2O3
Molecular Weight:202.59500
HS Code:2933199090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:324.917ºC at 760 mmHg
Density:1.438g/cm3
Index of Refraction:1.576
PSA:61.19000
Exact Mass:202.01500
LogP:0.58570

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 1H-PYRAZOLE-3-CARBOXYLIC ACID,5-(CHLOROCARBONYL)-1-METHYL-,METHYL ESTER chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-methyl-3-methoxycarbonylpyrazole-3-carboxylic acid chloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1H-PYRAZOLE-3-CARBOXYLIC ACID,5-(CHLOROCARBONYL)-1-METHYL-,METHYL ESTER Use and application,methyl5-(chlorocarbonyl)-1-methyl-1H-pyrazole-3-carboxylate technical grade,usp/ep/jp grade.


Related News: These mathematical dosing algorithms were developed in the Damiano Lab at Boston University and refined based on results from home-use clinical trials in adults and children with T1D. Beta Bionics is a Certified B Corporation? whose founders �� in addition to Ed Damiano �� include other parents of children with type 1 diabetes and people with type 1 diabetes. Beta Bionics is committed to acting in the best interests of the diabetes community and to profoundly disrupting the diabetes medical device industry by bringing the iLet to market as expeditiously and responsibly as possible. methyl 5-carbonochloridoyl-1-methylpyrazole-3-carboxylate manufacturer What’s more, also at the EHA meeting, BeiGene’s Brukinsa showed it could outperform Imbruvica at triggering tumor responses while causing fewer cases of atrial fibrillation, a potentially dangerous heart side effect, in its own head-to-head phase 3 study in previously treated CLL. methyl 5-carbonochloridoyl-1-methylpyrazole-3-carboxylate supplier These mathematical dosing algorithms were developed in the Damiano Lab at Boston University and refined based on results from home-use clinical trials in adults and children with T1D. Beta Bionics is a Certified B Corporation? whose founders �� in addition to Ed Damiano �� include other parents of children with type 1 diabetes and people with type 1 diabetes. Beta Bionics is committed to acting in the best interests of the diabetes community and to profoundly disrupting the diabetes medical device industry by bringing the iLet to market as expeditiously and responsibly as possible. methyl 5-carbonochloridoyl-1-methylpyrazole-3-carboxylate vendor There’s still hope for this approach to treating Alzheimer’s disease despite the somewhat mixed results from this trial, said Rebecca Edelmayer, senior director of scientific engagement at the Alzheimer’s Association. methyl 5-carbonochloridoyl-1-methylpyrazole-3-carboxylate factory These mathematical dosing algorithms were developed in the Damiano Lab at Boston University and refined based on results from home-use clinical trials in adults and children with T1D. Beta Bionics is a Certified B Corporation? whose founders �� in addition to Ed Damiano �� include other parents of children with type 1 diabetes and people with type 1 diabetes. Beta Bionics is committed to acting in the best interests of the diabetes community and to profoundly disrupting the diabetes medical device industry by bringing the iLet to market as expeditiously and responsibly as possible.